Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces
- PMID: 8665943
- DOI: 10.1111/j.1432-1033.1996.0240q.x
Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces
Abstract
The binding site of human factor XII (FXII) for negatively charged surfaces has been proposed to be localized in the N-terminal region of factor XII. We have generated two recombinant factor XII proteins that lack this region: one protein consisting of the second growth-factor-like domain, the kringle domain, the proline-rich region and the catalytic domain of FXII (rFXII-U-like), and another consisting of only 16 amino acids of the proline-rich region of the heavy-chain region and the catalytic domain (rFXII-1pc). Each recombinant truncated protein, as well as recombinant full-length FXII (rFXII), were produced in HepG2 cells and purified by immunoaffinity chromatography. The capability of these recombinant proteins to bind to negatively charged surfaces and to initiate contact activation was studied. Radiolabeled rFXII-U-like and, to a lesser extent, rFXII-lpc bound to glass in a concentration-dependent manner, yet with lower efficiency than rFXII. The binding of the recombinant proteins was inhibited by a 100-fold molar excess of non-labeled native factor XII. On native polyacrylamide gel electrophoresis, both truncated proteins appeared to bind also to dextran sulfate, a soluble negatively charged compound. Glass-bound rFXII-U-like was able to activate prekallikrein in FXII-deficient plasma (assessed by measuring the generation of kallikrein-C1-inhibitor complexes), but less efficiently than rFXII, rFXII-U-like and rFXII-lpc exhibited coagulant activity, but this activity was significantly lower than that of rFXII. These data confirm that the N-terminal part of the heavy-chain region of factor XII contains a binding site for negatively charged activating surfaces, and indicate that other sequences, possibly located on the second epidermal-growth-factor-like domain and/or the kringle domain, contribute to the binding of factor XII to these surfaces.
Similar articles
-
The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site for negatively charged surfaces.Blood. 1998 Dec 1;92(11):4198-206. Blood. 1998. PMID: 9834224
-
Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII--an immunochemical and homology modeling approach.Thromb Haemost. 2000 Dec;84(6):1057-65. Thromb Haemost. 2000. PMID: 11154114
-
Estrogen induction and contact phase activation of human factor XII.Steroids. 1996 Apr;61(4):270-6. doi: 10.1016/0039-128x(96)00037-2. Steroids. 1996. PMID: 8733013 Review.
-
Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein.Blood. 1995 Dec 1;86(11):4134-43. Blood. 1995. PMID: 7492770
-
Recent advances in factor XII structure and function.Curr Opin Hematol. 2022 Sep 1;29(5):233-243. doi: 10.1097/MOH.0000000000000727. Epub 2022 Jul 18. Curr Opin Hematol. 2022. PMID: 35916558 Free PMC article. Review.
Cited by
-
Clinical Utility Gene Card for hereditary angioedema with normal C1 inhibitor (HAEnC1).Eur J Hum Genet. 2017 Oct;25(10):e1-4. doi: 10.1038/ejhg.2017.104. Epub 2017 Jul 5. Eur J Hum Genet. 2017. PMID: 28905884 Free PMC article.
-
Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor.Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):15. doi: 10.1186/1710-1492-6-15. Allergy Asthma Clin Immunol. 2010. PMID: 20667118 Free PMC article.
-
Hereditary angioedema with normal c1 inhibition.Curr Allergy Asthma Rep. 2009 Jul;9(4):280-5. doi: 10.1007/s11882-009-0039-9. Curr Allergy Asthma Rep. 2009. PMID: 19656474
-
Cold-induced urticarial autoinflammatory syndrome related to factor XII activation.Nat Commun. 2020 Jan 10;11(1):179. doi: 10.1038/s41467-019-13984-8. Nat Commun. 2020. PMID: 31924766 Free PMC article.
-
In vivo roles of factor XII.Blood. 2012 Nov 22;120(22):4296-303. doi: 10.1182/blood-2012-07-292094. Epub 2012 Sep 19. Blood. 2012. PMID: 22993391 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources